Published in J Neurol Sci on October 26, 2005
Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol (2010) 1.59
Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr Dis Treat (2008) 1.21
Neuroprotective properties of chitosan and its derivatives. Mar Drugs (2010) 1.06
Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis (2012) 1.06
Neuroprotective effects of marine algae. Mar Drugs (2011) 1.04
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis (2010) 1.01
Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem (2009) 0.96
ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiol Aging (2012) 0.91
Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease. Front Cell Neurosci (2015) 0.91
PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. J Cell Mol Med (2009) 0.90
Alzheimer disease and platelets: how's that relevant. Immun Ageing (2012) 0.87
BACE1 as a potential biomarker for Alzheimer's disease. J Alzheimers Dis (2011) 0.87
Regulation of α-secretase ADAM10 expression and activity. Exp Brain Res (2011) 0.85
Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease. Alzheimers Res Ther (2013) 0.84
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. J Neural Transm (Vienna) (2012) 0.83
Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Acta Neuropathol Commun (2014) 0.82
Effects of oxidative stress on amyloid precursor protein processing in rat and human platelets. Platelets (2012) 0.82
Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? J Cell Mol Med (2008) 0.82
Platelets and Alzheimer's disease: Potential of APP as a biomarker. World J Psychiatry (2012) 0.81
Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology (2011) 0.81
Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets (2012) 0.80
Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol (2007) 0.80
Effects of ethanol on aggregation, serotonin release, and amyloid precursor protein processing in rat and human platelets. Platelets (2013) 0.79
Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline. Psychopharmacology (Berl) (2007) 0.78
Platelet biomarkers in Alzheimer's disease. World J Psychiatry (2012) 0.78
Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid. Mol Neurobiol (2016) 0.76
Platelets in psychiatric disorders. World J Psychiatry (2012) 0.76
Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease. Biogerontology (2015) 0.76
β-sitosterol inhibits high cholesterol-induced platelet β-amyloid release. J Bioenerg Biomembr (2011) 0.76
Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease. Curr Neurovasc Res (2013) 0.76
Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease. Aging Dis (2016) 0.75
Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study. J Alzheimers Dis (2015) 0.75
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. Curr Alzheimer Res (2015) 0.75
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell (1989) 4.99
BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci (2001) 4.54
Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci (1999) 3.77
The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol (1998) 3.45
Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science (1998) 3.21
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A (2001) 2.87
Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38
Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem (1997) 1.52
[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med (2002) 1.26
The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture. Neurology (2000) 1.15
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology (2004) 1.12
Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol (1997) 1.03
Platelet APP isoform ratios correlate with declining cognition in AD. Neurology (2000) 1.01
Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets. J Biol Chem (1995) 0.99
Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulation. J Biol Chem (2003) 0.93
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology (2003) 0.85
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology (2009) 3.88
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics (2006) 2.96
Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology (2012) 2.26
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Translational research in neurology and neuroscience 2010-2011. Arch Neurol (2010) 1.96
Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery (2003) 1.88
Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol (2004) 1.78
A SAS(®) macro implementation of a multiple comparison post hoc test for a Kruskal-Wallis analysis. Comput Methods Programs Biomed (2010) 1.78
Translating biomedical research to the bedside: a national crisis and a call to action. JAMA (2003) 1.63
Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology (2005) 1.60
Performance of elderly Native Americans and Caucasians on the CERAD Neuropsychological Battery. Alzheimer Dis Assoc Disord (2005) 1.60
An ecological study of the association of environmental chemicals on breast cancer incidence in Texas. Breast Cancer Res Treat (2005) 1.46
Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury. J Neurosurg (2013) 1.46
Deep vein harvest: predicting need for fasciotomy. J Vasc Surg (2004) 1.42
Reporting clinical trials: full access to all of the data. Arch Neurol (2002) 1.39
Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years. Am J Geriatr Psychiatry (2008) 1.39
Genome-wide association studies in Alzheimer disease. Arch Neurol (2008) 1.38
Clinical validation of FLACC: preverbal patient pain scale. Pediatr Nurs (2003) 1.37
Feasibility of telecognitive assessment in dementia. Assessment (2006) 1.30
Serum apoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol (2007) 1.29
Phthalate concentrations and dietary exposure from food purchased in New York State. Environ Health Perspect (2013) 1.19
The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. J Clin Neuromuscul Dis (2010) 1.17
Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice. J Neurol Sci (2007) 1.17
The PedsQL in pediatric patients with Spinal Muscular Atrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscul Disord (2009) 1.17
Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol (2010) 1.15
The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscul Disord (2006) 1.15
Cerebral autoregulation of blood velocity and volumetric flow during steady-state changes in arterial pressure. Hypertension (2013) 1.10
FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur Radiol (2005) 1.09
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA (2009) 1.07
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice. J Neurol Sci (2006) 1.05
Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol (2006) 1.03
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation. Cell Mol Neurobiol (2011) 1.02
Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil. J Speech Lang Hear Res (2004) 1.02
Prenatal depression in women hospitalized for obstetric risk. J Clin Psychiatry (2008) 1.02
Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology (2007) 1.00
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease. Vaccine (2010) 1.00
The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 0.99
Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation. Clin Nucl Med (2006) 0.98
When policy meets statistics: the very real effect that questionable statistical analysis has on limiting health care access for bariatric surgery. Arch Surg (2007) 0.98
Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol (2003) 0.98
Advances in the development of vaccines for Alzheimer's disease. Discov Med (2013) 0.97
Comparison of the test of everyday functional abilities with a direct measure of daily function. Dement Geriatr Cogn Disord (2006) 0.97
Reliability of 4 outcome measures in pediatric spinal muscular atrophy. Arch Neurol (2003) 0.97
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease. J Neuroimmunol (2012) 0.94
Prevalence of vulvar pain in an urban, minority population. J Reprod Med (2007) 0.94
The test of infant motor performance: reliability in spinal muscular atrophy type I. Pediatr Phys Ther (2008) 0.94
Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically? J Geriatr Psychiatry Neurol (2003) 0.93
Management of small polyps detected by screening CT colonography: patient and physician preferences. Am J Med (2009) 0.93
Lateralization on neuroimaging does not differentiate frontotemporal lobar degeneration from Alzheimer's disease. Dement Geriatr Cogn Disord (2004) 0.93
Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J Nucl Med (2004) 0.93
Consumer acceptability of brief videoconference-based neuropsychological assessment in older individuals with and without cognitive impairment. Clin Neuropsychol (2013) 0.92
Can a direct IADL measure detect deficits in persons with MCI? Curr Alzheimer Res (2009) 0.92
Dyadic short forms of the Wechsler Adult Intelligence Scale-III. Assessment (2002) 0.92
International Paediatric Stroke Study: stroke associated with cardiac disorders. Int J Stroke (2012) 0.91
Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Mol Genet Metab (2012) 0.91
Lipids and adipokines as risk factors for Alzheimer's disease. J Alzheimers Dis (2012) 0.90
An ecological study of the association of metal air pollutants with lung cancer incidence in Texas. J Thorac Oncol (2006) 0.90
A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. J Clin Psychopharmacol (2007) 0.89
Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig Dis Sci (2013) 0.89
Rasch analysis of clinical outcome measures in spinal muscular atrophy. Muscle Nerve (2013) 0.89
Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int (2014) 0.89
Risk of residual breast tissue after skin-sparing mastectomy. Breast J (2012) 0.88
Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels. Hepatology (2012) 0.88
Convergence of connected language and SPECT in variants of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord (2005) 0.88
MMSE scores decline at a greater rate in frontotemporal degeneration than in AD. Dement Geriatr Cogn Disord (2006) 0.88
Comprehensive proficiency-based inanimate training for robotic surgery: reliability, feasibility, and educational benefit. Surg Endosc (2012) 0.88
Polyfluoroalkyl compounds in Texas children from birth through 12 years of age. Environ Health Perspect (2011) 0.87
Fetal central nervous system biometry on MR imaging. AJR Am J Roentgenol (2003) 0.87
Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury. J Neurosurg (2014) 0.87
False positive acetaminophen concentrations in patients with liver injury. Clin Chim Acta (2008) 0.87
The association of pretreatment health-related quality of life with surgical complications for patients undergoing open surgical resection for colorectal cancer. Ann Surg (2003) 0.87
Prompt control of an outbreak caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Pediatr (2013) 0.86
Hexabromocyclododecane (HBCD) stereoisomers in U.S. food from Dallas, Texas. Environ Health Perspect (2012) 0.86
Treat Alzheimer disease before it is symptomatic. Arch Neurol (2011) 0.85
Characterization of Atrophic Changes in the Cerebral Cortex Using Fractal Dimensional Analysis. Brain Imaging Behav (2009) 0.85
Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancer. Surgery (2003) 0.85
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol (2015) 0.84
Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol (2010) 0.83
Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease. Transl Neurosci (2012) 0.83
Ocular findings as predictors of carotid artery occlusive disease: is carotid imaging justified? J Vasc Surg (2004) 0.83
Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. J Med Virol (2014) 0.83
Prion proteins: physiological functions and role in neurological disorders. J Neurol Sci (2007) 0.83
Androgen receptor gene and sex-specific Alzheimer's disease. Neurobiol Aging (2013) 0.83
Leptin and cognition. Dement Geriatr Cogn Disord (2012) 0.83
An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening. Clin Neuropsychol (2015) 0.83
Dementia diagnosis, treatment, and research with American Indians. Alzheimers Dement (2006) 0.82
Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscul Disord (2010) 0.82
Comparison of Alzheimer's disease in Native Americans and Whites. Int Psychogeriatr (2003) 0.82
A randomized, controlled study of an Alzheimer's caregiver skills training program. Am J Alzheimers Dis Other Demen (2005) 0.82
Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia. Dement Geriatr Cogn Disord (2004) 0.82
A direct functional measure to help ascertain optimal level of residential care. Am J Alzheimers Dis Other Demen (2007) 0.81